Viatris Will Tread A Different Path
Mylan-Upjohn Combination Neither Pure Generics Nor Big Pharma Player
By merging to create Viatris, Mylan and Pfizer’s Upjohn unit intend to occupy a space between generics players and big pharma by offering a broad array of affordable products all around the world.
